Joseph Miller
Director of Finance/CFO bij AURINIA PHARMACEUTICALS INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Joseph M.
Miller is currently the Chief Financial Officer at Aurinia Pharmaceuticals, Inc. He previously worked as the Senior Director-Accounting at Qiagen Genomics, Inc. from 2006 to 2015.
From 2018 to 2022, he served as the Director at Avalo Therapeutics, Inc. Prior to that, he was the Vice President-Finance at Sucampo Pharmaceuticals LLC from 2015 to 2018.
Mr. Miller also held the position of Chief Financial Officer & Vice President-Finance at Eppendorf-5 Prime, Inc. from 2002 to 2006.
He obtained his undergraduate degree from Villanova University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
06-03-2024 | 495 928 ( 0.34% ) | 2 M $ | 31-03-2024 |
Actieve functies van Joseph Miller
Bedrijven | Functie | Begin |
---|---|---|
AURINIA PHARMACEUTICALS INC. | Director of Finance/CFO | 27-04-2020 |
Eerdere bekende functies van Joseph Miller
Bedrijven | Functie | Einde |
---|---|---|
AVALO THERAPEUTICS, INC. | Director of Finance/CFO | 24-04-2020 |
SUCAMPO PHARMACEUTICALS, INC. | Director of Finance/CFO | 01-04-2018 |
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA. | Comptroller/Controller/Auditor | 01-01-2015 |
Eppendorf-5 Prime, Inc. | Director of Finance/CFO | 01-01-2006 |
Opleiding van Joseph Miller
Villanova University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AVALO THERAPEUTICS, INC. | Health Technology |
AURINIA PHARMACEUTICALS INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Eppendorf-5 Prime, Inc. |